A large real-world study examines outcomes and treatment patterns among patients with non-muscle-invasive bladder cancer treated with BCG.
Flaig: It has been a remarkable 10 years for bladder cancer. If you think back to 10 or 15 years ago, we had no new ...
( NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced it will present new treatment comparison results evaluating ANKTIVA ® (nogapendekin alfa inbakicept-pmln) plus Bacillus ...
SurvivorNet on MSN
After A Bladder Cancer Diagnosis At 39, Groundbreaking New Treatment Option Inlexzo Allows Texas Man To Avoid Surgery & Get Back To An Active Life
Jimi Stewart, a rollerblading enthusiast from Austin, Texas, was diagnosed with a type of non-muscle invasive bladder cancer ...
As new therapies emerge, particularly for non-muscle invasive disease, clinicians and patients are faced with increasingly ...
Most people with bladder cancer begin treatment by having surgery to remove their cancer. If bladder cancer has spread beyond your bladder, you might have chemotherapy first. This can help treat ...
But when Jimi began experiencing bladder cancer symptoms, including blood in his urine, he felt a different kind of rush. It ...
The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...
ImmunityBio will present new findings on its Anktiva immunotherapy combined with BCG for non-muscle-invasive bladder cancer ...
In a phase 2 study, researchers added pembrolizumab to chemoradiation and surgery for muscle-invasive bladder cancer. 60 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results